Home › Candida Nail Infection
Candida Nail Infection: Symptoms, Treatment, and How It Differs from Tinea
By Best Toenail Fungus Treatments · Reviewed 15 Nov 2026 · 11 min read

Home › Candida Nail Infection
By Best Toenail Fungus Treatments · Reviewed 15 Nov 2026 · 11 min read

From Diagnosis to a Clear Nail
| Lab test | Treatment | Fingernails | Toenails |
|---|---|---|---|
| Fungal culture takes 2–6 weeks | Oral antifungal for about 3–6 months | Full regrowth in about 6 months | Full regrowth in 12–18 months |
Key Facts
Share of cases
About 5–10% of nail fungus
How it’s diagnosed
Lab confirmation; looks alone can’t tell
Most affects
Fingernails; wet-work hands
First-line Rx
Fluconazole or itraconazole
Nail fungus (onychomycosis) is usually caused by dermatophyte fungi, particularly Trichophyton rubrum and Trichophyton mentagrophytes. These account for approximately 90% of nail fungus cases (Elewski BE, Clin Microbiol Rev 1998).
Candida species — most often Candida albicans, but also C. parapsilosis and C. tropicalis — cause a smaller share of nail infections than dermatophytes.
Candida typically enters via the nail fold (proximal or lateral), often associated with chronic paronychia (swelling and inflammation around the nail fold). This entry pattern differs from dermatophyte onychomycosis, which usually starts at the distal free edge of the nail.

Candida nail infection can appear in several patterns:
Important: You cannot reliably identify whether nail changes are caused by Candida or dermatophytes based on appearance alone. Other non-fungal conditions (nail psoriasis, trauma, lichen planus, bacterial infection) can look similar. Lab testing is needed to confirm onychomycosis and identify the pathogen.
Because Candida and dermatophyte nail infections look similar and require different treatments, lab testing is not optional — it determines which antifungal to use. Learn how toenail fungus is diagnosed →
Treatment differs from dermatophyte onychomycosis. The choice depends on severity, location (fingernail vs toenail), immune status, and concurrent paronychia.
Topical agents (ciclopirox nail lacquer, amorolfine) may be used adjunctively or for mild superficial cases, but nail penetration is limited. They are generally insufficient as monotherapy for established Candida nail infection.
If chronic paronychia (nail fold inflammation) is present alongside the nail infection, it must be treated concurrently. Keeping the nail fold dry, avoiding wet work, and treating Candida in the nail fold (topical or oral azole) are all important for preventing recurrence.
Candida is a yeast and can cause nail infections (Candida onychomycosis), but most toenail fungus is caused by dermatophyte fungi (mainly Trichophyton rubrum). Candida nail infections account for about 5–10% of onychomycosis cases and are more common on fingernails than toenails. Lab testing is needed to distinguish them.
Terbinafine is not reliably active against Candida species. It is highly effective against dermatophytes (tinea nail infections) but should not be used as monotherapy for confirmed Candida onychomycosis. Fluconazole or itraconazole are preferred for Candida infections.
Treatment typically takes 3–6 months of oral antifungal therapy. Nails grow slowly (fingernails ~6 months, toenails 12–18 months for full regrowth), so clinical improvement is gradual even after the infection is mycologically cleared. Recurrence is common if the underlying risk factors (wet work, immune status) are not addressed.
No home remedy has been shown in clinical trials to clear Candida nail infection. Because the treatment for Candida differs from treatment for dermatophyte infection, it is important to get a confirmed lab diagnosis before starting any treatment. See a clinician for testing and prescription treatment.
Medical disclaimer: This page is informational only and not medical advice. Consult a licensed clinician for diagnosis and treatment of nail infections.
Sources: Elewski BE. Clin Microbiol Rev 1998;11(3):415–429 (onychomycosis overview); Pappas PG et al. Clin Infect Dis 2016;62(4):e1–50 (IDSA Candida guidelines); AAFP 2015 (prevalence 3–12%).
Use our finder to understand your options and when to see a clinician.